Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study

European Neuropsychopharmacology

Volumn 25, Issue 2, 2015, Pages 223-230

  Muralidharan, Kesavan ^a,b   Kozicky, Jan Marie ^b   Bücker, Joana ^b,c,d   Silveira, Leonardo E ^b,c,d   Torres, Ivan J ^b   Yatham, Lakshmi N ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; Cognitive functions; First episode mania; Lithium; Valproate; Working memory

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; VALPROIC ACID; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ARTICLE; ATTENTION; BIPOLAR DISORDER; BIPOLAR I DISORDER; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MEMORY; PRIORITY JOURNAL; REMISSION; VELOCITY; VERBAL MEMORY; WORKING MEMORY; COMPARATIVE STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ANTIMANIC AGENTS; BIPOLAR DISORDER; COGNITION DISORDERS; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; NEUROPSYCHOLOGICAL TESTS; VALPROIC ACID; YOUNG ADULT;

EID: 84933050889     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.09.005     Document Type: Article

References (55)

1. Ananth J., Engelsmann F., Kiriakos R. Evaluation of lithium response. Psychometric findings. Can. J. Psychiatry 1980, 25:151-154.
2. Burdick K.E., Goldberg T.E., Cornblatt B.A., Keefe R.S., Gopin C.B., Derosse P., Braga R.J., Malhotra A.K. The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2011, 36:1587-1592.
3. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test 2000, (Adult Version), The Psychological Corporation, San Antonio. Second edition.
4. Dias V.V., Balanzá-Martinez V., Soeiro-de-Souza M.G., Moreno R.A., Figueira M.L., Machado-Vieira R., Vieta E. Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview. Acta Psychiatr. Scand. 2012, 126:315-331.
5. Ehninger D., Kempermann G. Neurogenesis in the adult hippocampus. Cell Tissue Res 2008, 331:243-250.
6. Goldberg J.F., Burdick K.E. Cognitive side effects of anticonvulsants. J. Clin. Psychiatry 2001, 62(Suppl. 1):S27-S33.
7. Golden C.J., Freshwater S.M. A Manual for the Adult Stroop Color and Word Test 2002, Stoelting, Chicago.
8. Gualtieri C.T., Johnson L.G. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed: Medscape Gen. Med. 2006, 8:46.
9. Hasselbalch B.J., Knorr U., Hasselbalch S.G., Gade A., Kessing L.V. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur. Psychiatry: J. Assoc. Eur. Psychiatr. 2013, (28):349-355.
10. Hellvin T., Sundet K., Simonsen C., Aminoff S.R., Lagerberg T.V., Andreassen O.A., Melle I. Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord. 2012, 14:227-238.
11. Hirsch E., Schmitz B., Carreño M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol. Scand. Suppl. 2003, 180:23-32.
12. Holmes M.K., Erickson K., Luckenbaugh D.A., Drevets W.C., Bain E.E., Cannon D.M., Snow J., Sahakian B.J., Manji H.K., Zarate C.A. A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disord. 2008, 10:806-815.
13. Hommet C., Mondon K., de Toffol B., Constans T. Reversible cognitive and neurological symptoms during valproic acid therapy. J. Am. Geriatr. Soc. 2007, 55:628.
14. Honig A., Arts B.M., Ponds R.W., Riedel W.J. Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. Int. Clin. Psychopharmacol. 1999, 14:167-171.
15. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. USA 2004, 101:16659-16664.
16. Jamrozinski K., Gruber O., Kemmer C., Falkai P., Scherk H. Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr. Scand. 2009, 119:365-374.
17. Joffe R.T., MacDonald C., Kutcher S.P. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J. Clin. Psychopharmacol. 1988, 8:425-428.
18. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
19. Kitabatake Y., Sailor K.A., Ming G., Song H. Adult neurogenesis and hippocampal memory function: new cells, more plasticity, new memories?. Neurosurg. Clin. N. Am. 2007, 18:105-113. (x).
20. Kocsis J.H., Shaw E.D., Stokes P.E., Wilner P., Elliot A.S., Sikes C., Myers B., Manevitz A., Parides M. Neuropsychologic effects of lithium discontinuation. J. Clin. Psychopharmacol. 1993, 13:268-275.
21. Kozicky J.-M., Torres I.J., Bond D.J., Lam R.W., Yatham L.N. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. Int. Clin. Psychopharmacol. 2012, 27:91-99.
22. Lezak M.D. Neuropsychological Assessment 2004, Oxford University Press, New York. 2nd edition.
23. López-Jaramillo C., Lopera-Vásquez J., Ospina-Duque J., García J., Gallo A., Cortez V., Palacio C., Torrent C., Martínez-Arán A., Vieta E. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J. Clin. Psychiatry 2010, 71:1055-1060.
24. Loring D.W., Meador K.J. Cognitive side effects of antiepileptic drugs in children. Neurology 2004, 62:872-877.
25. Lossius M.I., Hessen E., Mowinckel P., Stavem K., Erikssen J., Gulbrandsen P., Gjerstad L. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia 2008, 49:455-463.
26. Monks P.J., Thompson J.M., Bullmore E.T., Suckling J., Brammer M.J., Williams S.C.R., Simmons A., Giles N., Lloyd A.J., Harrison C.L., Seal M., Murray R.M., Ferrier I.N., Young A.H., Curtis V.A. A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disord. 2004, 6:550-564.
27. Moore G.J., Cortese B.M., Glitz D.A., Zajac-Benitez C., Quiroz J.A., Uhde T.W., Drevets W.C., Manji H.K. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J. Clin. Psychiatry 2009, 70:699-705.
28. Mora E., Portella M.J., Forcada I., Vieta E., Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol. Med. 2013, 43:1187-1196.
29. Muralidharan K., Torres I.J., Silveira L.E., Kozicky J.M., Bücker J., Fernando N., Yatham L.N. Impact of depressive episodes on cognitive deficits in early bipolar disorder: data from the Systematic Treatment Optimization Programme for Early Mania (STOP-EM). Br J Psychiatry 2014, 205:36-43.
30. Nuechterlein K.H., Green M.F., Kern R.S., Baade L.E., Barch D.M., Cohen J.D., Essock S., Fenton W.S., Frese F.J., Gold J.M., Goldberg T., Heaton R.K., Keefe R.S.E., Kraemer H., Mesholam-Gately R., Seidman L.J., Stover E., Weinberger D.R., Young A.S., Zalcman S., Marder S.R. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am. J. Psychiatry 2008, 165:203-213.
31. Nunes P.V., Forlenza O.V., Gattaz W.F. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br. J. Psychiatry: J Ment. Sci. 2007, 190:359-360.
32. Qiu H.M., Yang J.X., Liu D., Fei H.Z., Hu X.Y., Zhou Q.X. Antidepressive effect of sodium valproate involving suppression of corticotropin-releasing factor expression and elevation of BDNF expression in rats exposed to chronic unpredicted stress. Neuroreport 2014, 25(4):205-210.
33. Reitan R.M., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery 1985, Neuropsychology Press, Tucson.
34. Robbins T.W., James M., Owen A.M., Sahakian B.J., McInnes L., Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994, 5:266-281.
35. Robinson L.J., Ferrier I.N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord. 2006, 8:103-116.
36. Rybakowski J.K., Suwalska A. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int. J. Neuropsychopharmacol./Off. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP) 2010, 13:617-622.
37. Senturk V., Goker C., Bilgic A., Olmez S., Tugcu H., Oncu B., Atbasoglu E.C. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord. 2007, 9(Suppl. 1):S136-S144.
38. Shaw E.D., Stokes P.E., Mann J.J., Manevitz A.Z. Effects of lithium carbonate on the memory and motor speed of bipolar outpatients. J. Abnorm. Psychol. 1987, 96:64-69.
39. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The J. Clin. Psychiatry 1998, 59(Suppl. 2):S22-S33. (quiz 34-57).
40. Torres I.J., Boudreau V.G., Yatham L.N. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr. Scand. Suppl. 2007, 116:17-26.
41. Torres I.J., DeFreitas C.M., DeFreitas V.G., Bond D.J., Kunz M., Honer W.G., Lam R.W., Yatham L.N. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder. Psychol. Med. 2011, 41:971-982.
42. Torres I.J., DeFreitas V.G., DeFreitas C.M., Kauer-Sant'Anna M., Bond D.J., Honer W.G., Lam R.W., Yatham L.N. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J. Clin. Psychiatry 2010, 71:1234-1242.
43. Umka J., Mustafa S., ElBeltagy M., Thorpe A., Latif L., Bennett G., Wigmore P.M. Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 2010, 166:15-22.
44. Vieta E. The influence of medications on neurocognition in bipolar disorder. Acta Psychiatr. Scand. 2009, 120:414-415.
45. Wechsler D. The Wechsler Memory Scale-III manual 1997, The Psychological Corporation, San Antonio.
46. Williams J.B.W., Link M.J., Rosenthal N.E., Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD) 1988, New York State Psychiatric Institute, New York.
47. Wingo A.P., Harvey P.D., Baldessarini R.J. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord. 2009, 11:113-125.
48. Wingo A.P., Wingo T.S., Harvey P.D., Baldessarini R.J. Effects of lithium on cognitive performance: a meta-analysis. J. Clin. Psychiatry 2009, 70:1588-1597.
49. Yatham L.N., Kauer-Sant'Anna M., Bond D.J., Lam R.W., Torres I. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can. J. Psychiatry 2009, 54:105-112.
50. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S.V., MacQueen G., McIntyre R.S., Sharma V., Beaulieu S. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006, 8:721-739.
51. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., Sharma V., Silverstone P., Alda M., Baruch P., Beaulieu S., Daigneault A., Milev R., Young L.T., Ravindran A., Schaffer A., Connolly M., Gorman C.P. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005, 7(Suppl. 3):S5-S69.
52. Yatham L.N., Kennedy S.H., Parikh S.V., Schaffer A., Beaulieu S., Alda M., O'Donovan C., Macqueen G., McIntyre R.S., Sharma V., Ravindran A., Young L.T., Milev R., Bond D.J., Frey B.N., Goldstein B.I., Lafer B., Birmaher B., Ha K., Nolen W.A., Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013, 15:1-44.
53. Yatham L.N., Kennedy S.H., Schaffer A., Parikh S.V., Beaulieu S., O'Donovan C., MacQueen G., McIntyre R.S., Sharma V., Ravindran A., Young L.T., Young A.H., Alda M., Milev R., Vieta E., Calabrese J.R., Berk M., Ha K., Kapczinski F. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009, 11:225-255.
54. Yatham L.N., Torres I.J., Malhi G.S., Frangou S., Glahn D.C., Bearden C.E., Burdick K.E., Martínez-Arán A., Dittmann S., Goldberg J.F., Ozerdem A., Aydemir O., Chengappa K.N.R. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord. 2010, 12:351-363.
55. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry: JMent. Sci. 1978, 133:429-435.